| Pharmaceutical Information |
| Drug Name |
Myristyl sulfate |
| Drug ID |
BADD_D01509 |
| Description |
An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins. |
| Indications and Usage |
For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves. |
| Marketing Status |
approved; investigational |
| ATC Code |
C05BB04 |
| DrugBank ID |
DB00464
|
| KEGG ID |
D06882
|
| MeSH ID |
D012981
|
| PubChem ID |
5248
|
| TTD Drug ID |
D0Z5SM
|
| NDC Product Code |
29902-0015; 24201-201; 57821-005; 51662-1562 |
| UNII |
6VOC18EIBH
|
| Synonyms |
Sodium Tetradecyl Sulfate | Sulfate, Sodium Tetradecyl | Tetradecyl Sulfate, Sodium | Tergitol 4 | Trombavar | Trombovar | Sotradecol Sodium | Sotradecol |
|
| Chemical Information |
| Molecular Formula |
C14H30O4S |
| CAS Registry Number |
4754-44-3 |
| SMILES |
CCCCCCCCCCCCCCOS(=O)(=O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
